Revenue and Profitability - The company's revenue for Q1 2025 was ¥334,826,473.57, representing a 36.30% increase compared to ¥245,661,340.36 in the same period last year[5] - Net profit attributable to shareholders decreased by 30.57% to ¥25,367,991.11 from ¥36,536,964.44 year-on-year[5] - The company's revenue for Q1 2025 reached approximately $421.37 million, representing a 70.62% increase compared to $246.96 million in Q1 2024, primarily due to increased sales collections during the reporting period[10] - The net profit for the current period is CNY 32,639,730.77, a decrease of 22.5% compared to CNY 42,043,413.09 in the previous period[19] - The total comprehensive income for the current period is CNY 31,598,954.23, down from CNY 42,896,727.47 in the previous period, reflecting a decline of 26.2%[20] Cash Flow and Liquidity - The net cash flow from operating activities improved significantly, reaching ¥25,958,892.54, a 197.20% increase from a negative cash flow of ¥26,707,437.55 in the previous year[5] - Cash flow from operating activities generated a net amount of CNY 25,958,892.54, a significant improvement from a net outflow of CNY 26,707,437.55 in the previous period[21] - The net increase in cash and cash equivalents was approximately $10.49 million in Q1 2025, a significant improvement from a net decrease of approximately $109.54 million in Q1 2024, mainly due to increased sales collections[10] - Cash and cash equivalents at the end of the period increased to CNY 426,542,804.32 from CNY 607,367,176.53, a decrease of 29.7%[21] Expenses and Costs - Basic and diluted earnings per share fell by 29.62% to ¥0.1347 from ¥0.1914 in the same period last year[5] - Total operating costs amounted to ¥304,754,974.14, up from ¥202,272,926.05, indicating an increase of about 50.6%[18] - Research and development expenses rose by 63.00% to ¥6,794,990.41, reflecting the company's increased focus on new product development[8] - Sales expenses surged by 96.23% to ¥13,392,044.39, attributed to the expansion of domestic business operations[8] Assets and Liabilities - Total assets increased by 0.76% to ¥1,717,091,835.86 compared to ¥1,704,105,748.93 at the end of the previous year[5] - The total liabilities decreased to ¥199,848,747.07 from ¥218,461,614.37, indicating a reduction of approximately 8.5%[17] - The company's total liabilities decreased by 37.92% in tax payable, amounting to ¥8,083,316.91 compared to ¥13,019,906.76 previously[8] Shareholder Information - The total number of common shareholders at the end of the reporting period was 12,623, with no preferred shareholders having restored voting rights[11] - The largest shareholder, Zhuang Mingyun, holds 28.06% of the shares, amounting to approximately 53.56 million shares[11] - The second-largest shareholder, Zhu Xiaorong, owns 13.23% of the shares, equivalent to approximately 25.26 million shares[11] Investment Activities - The company plans to change the use of part of the raised investment projects, reallocating funds to a new pet food project with a capacity of 22,000 tons[14] - The company adjusted the internal investment structure of the R&D center project, reducing the investment scale to supplement working capital[14] - The company reported a decrease in other comprehensive income attributable to owners of the parent company, with a net amount of CNY -813,420.54 compared to CNY 623,723.79 in the previous period[20] Other Financial Metrics - The gross profit margin for the current period is approximately 8.9%, down from the previous period's margin, reflecting increased costs[18] - The company reported a total operating profit of CNY 33,927,327.33, down 21.5% from CNY 43,326,494.71 in the previous period[19] - The company incurred credit impairment losses of CNY 2,543,084.26, compared to a gain of CNY 249,773.79 in the previous period, indicating a significant negative shift[19] - The company reported a significant decrease in investment income, down 72.23% to ¥235,531.73, due to reduced returns from associated enterprises[8]
源飞宠物(001222) - 2025 Q1 - 季度财报